Lanean...
RET Fusion as a Novel Driver of Medullary Thyroid Carcinoma
INTRODUCTION: Oncogenic RET tyrosine kinase gene fusions and activating mutations have recently been identified in lung cancers, prompting initiation of targeted therapy trials in this disease. Although RET point mutation has been identified as a driver of tumorigenesis in medullary thyroid carcinom...
Gorde:
| Argitaratua izan da: | J Clin Endocrinol Metab |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Endocrine Society
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4333032/ https://ncbi.nlm.nih.gov/pubmed/25546157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-4153 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|